The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

USA: A recent economic evaluation has highlighted the significant long-term health benefits of tirzepatide and semaglutide in ...

According to the arrest documents, two of the drugs found in the lollipops are the active ingredients of popular weight-loss ...

Among all antiobesity medications, the incremental cost-effectiveness ratios were $197,023 and $467,676 per quality-adjusted life-year for tirzepatide and semaglutide, respectively. HealthDay News ...